FORE Biotherapeutics has completed target enrolment in the primary central [...]

PhoreMost has unveiled its lead oncology programme, PMC-001, as the [...]

CuraCell TX has reported new findings supporting its personalised tumour-infiltrating [...]

Medicines Discovery Catapult (MDC) and King’s College London (KCL) have [...]

Carthera has enrolled the first 100 participants in its Sonobird [...]